Target intelligence / Profile preview

Immunoglobulin lambda variable 6-57 (IGLV6-57)

Target
IGLV6-57
Molecular classification
Immunoglobulin variable region gene, Immunoglobulin variable domain, Antibody fragment
01

Overview

Immunoglobulin lambda variable 6-57 (IGLV6-57) is a variable region gene segment of the lambda light chain locus in human immunoglobulins. It encodes the variable (V) domain of lambda light chains, which combine with heavy chain variable domains to form the antigen-binding site of antibodies. V-region segments undergo recombination and hypermutation to provide antibody diversity. IGLV6-57-derived light chains are expressed in a minority of plasma cells, but are overrepresented in pathological monoclonal light chain production, especially in AL amyloidosis, where they are prone to misfolding and aggregation into amyloid fibrils. IGLV6-57 variable domains play a specific structural and physicochemical role in amyloid fibril formation, and their sequence features affect susceptibility to pathogenic aggregation[2][4]. IGLV6-57 is not a conventional therapeutic target like a receptor or enzyme, but its sequence and products are important as biomarkers in amyloidosis and for understanding antibody diversity[2][4][3].

Other names
Immunoglobulin lambda variable 6-57IGLV6-57Ig lambda chain V-VI region ARIg lambda chain V-VI region EB4Ig lambda chain V-VI region NIG-48Ig lambda chain V-VI region SUTIg lambda chain V-VI region WLTIGLV657V1-22amyloid lambda 6 light chain variable region PIPamyloid lambda 6 light chain variable region SAR
02

Biological functions

Antigen bindingImmune responseHumoral immunity
03

Disease associations

AmyloidosisPart of immunoglobulin genesNot a primary disease driver but associated when mutated or misfolded
04

Safety considerations

Potential for amyloid aggregation implicated in AL amyloidosis
05

Biomarkers

Amyloidogenic light chain in AL (amyloid light-chain) amyloidosis

Beyond the preview

Go deeper on Immunoglobulin lambda variable 6-57 (IGLV6-57).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 6-57 (IGLV6-57).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call